SMAD4 and cancer: As PI3K/Akt signaling is a known regulator of p21 in cancer [26], to elucidate the SMAD4-independent signaling of activin in colon cancer, we hypothesized that the activin receptor directly engages the PI3K/Akt pathway upstream of SMAD4.